{
    "id": "0857",
    "question": "A 71-year-old woman comes to the physician for evaluation of a pigmented lesion on her left foot. She has had decreased appetite and a 6-kg (13-lb) weight loss in the past 2 months. Physical examination shows that on the left medial ankle there is a 2-cm reddish-black nodule with a verrucous surface. A full-thickness excisional biopsy of the lesion shows S100-protein-positive epithelioid cells. A subsequent CT scan of the chest, abdomen, and pelvis shows metastases to the liver; a diagnosis of metastatic melanoma is made. Chemotherapy with aldesleukin is initiated. Which of the following is the mechanism of action for this drug?",
    "options": {
        "A": "Stimulating release of acute-phase reactants",
        "B": "Stimulating antigen-processing cells",
        "C": "Activating natural killer cells and cytotoxic T cells",
        "D": "Supporting growth of bone marrow stem cells"
    },
    "answer": "C",
    "predict": "{\"step_by_step_thinking\": \"The question requires understanding the mechanism of action of aldesleukin, which is a recombinant interleukin-2 (IL-2). To answer this question, we need to analyze the properties and functions of IL-2. IL-2 is a type of cytokine that plays a crucial role in the immune response, particularly in the activation and proliferation of T cells, which are a type of white blood cell that plays a key role in cell-mediated immunity. Option A, stimulating release of acute-phase reactants, is not accurate for IL-2. Acute-phase reactants are proteins that are produced in response to inflammation, and while IL-2 may have some effects on inflammation, this is not its primary mechanism of action. Option B, stimulating antigen-processing cells, is also incorrect. Antigen-processing cells, such as dendritic cells, are responsible for processing and presenting antigens to T cells, but IL-2's primary function is not to stimulate these cells. Option D, supporting growth of bone marrow stem cells, is not relevant to IL-2's mechanism of action. IL-2's primary function is not to support the growth of bone marrow stem cells. Option C, activating natural killer cells and cytotoxic T cells, is the correct answer. IL-2 is a potent stimulator of T cell growth and activation, and it plays a key role in the activation of natural killer cells and cytotoxic T cells, which are essential for cell-mediated immunity. By activating these cells, IL-2 can help the body's immune system to recognize and destroy cancer cells, making it an effective treatment for certain types of cancer, including melanoma.\", \"answer_choice\": \"C\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 38.92117404937744
}